Shantai Health Files IPO Prospectus: Pioneer in Integrating Insurance Coverage with Healthcare Services

Protection and service alike! Enhanced user experience alongside cost control! These are the respective expectations of current policyholders and insurance companies.

On June 16, 2022, Pacific Insurance launched the Jia An Xin series of insurance products, addressing the aforementioned two expectations.

Jia An Xin is a million-yuan medical insurance product designed for the general population, including both individuals with pre-existing conditions and healthy individuals. Jointly developed by CPIC Life Insurance and CPIC Health Insurance, subsidiaries of China Pacific Insurance (Group) Co., Ltd. (CPIC), and Shanghai Shantai Health Technology Co., Ltd. (hereinafter referred to as “Shantai Health”), it enables underwriting for patients with more than 20 types of chronic diseases and provides managed care services tailored to six key groups: healthy individuals, and those with breast nodules, thyroid nodules, pulmonary nodules, diabetes, or hypertension.

Jia An Xin provides each insured client with exclusive family doctor services, delivering 24/7 online care through WeChat and other internet-based technologies. Grounded in authoritative domestic and international clinical practice guidelines for disease diagnosis and treatment, Jia An Xin’s condition-specific management programs feature proactive physician communication and care, timely reminders for monitoring and follow-up examinations, active intervention on risk factors, and regular reporting on health management progress. Furthermore, by tracking clients’ long-term health management data, the company establishes a statistical data foundation for modeling healthcare service costs and developing differentiated insurance products tailored to high-risk populations.

Jia Anxin’s medical services originated from Shantai Health, a company jointly established by China Pacific Insurance and Sequoia Capital China. Committed to advancing the development of “Internet + Healthcare,” it leverages technology to build a healthcare service platform that extensively connects multi-dimensional medical resources. Currently, its “Taiyi Guanjia” platform, launched less than a year ago, has already amassed over 2 million users. Supported by an in-house team of approximately 300 full-time medical professionals and deeply integrated with more than 500 renowned specialists from top-tier (Grade III Class A) hospitals across China, the platform enables efficient and convenient comprehensive tracking of patients’ condition progression. It provides health management services encompassing both healthy lifestyle guidance and disease management, thereby closing the loop between home-based and hospital-based care and significantly enhancing customer experience.

The “Taiyi Guanjia” platform is currently accelerating the construction of an integrated healthcare ecosystem encompassing health management, insurance products, and medical services. We have good reason to expect that numerous outstanding innovative products, including Jia An Xin, will continue to emerge.